CD&R, McKesson acquiring infusion therapy provider Option Care Health for $5.8B
Option Care Health, the country's largest independent provider of at-home and alternate site infusion services, would go private in the deal, which is expected to close in the first half of 2027.
Private equity firm CD&R and healthcare conglomerate McKesson have agreed to acquire infusion therapy provider Option Care Health for $5.8 billion. The deal, which will take Option private at a per-share offer price of $32.05, represents a 37% premium over the company's closing price. The purchase is expected to close in the first half of 2027, contingent on regulatory approvals and shareholder approval.
CD&R will hold a 51% stake in the company, while McKesson will own approximately 49%, with an investment of around $1.4 billion.
John Rademacher, CEO of Option Care Health, expressed his commitment to enhancing the company's platform and deepening partnerships with various stakeholders. Option Care Health is the largest independent provider of at-home and alternate site infusion services in the United States, operating in all 50 states, caring for over 308,000 patients annually, and employing 8,000 people, including 5,000 clinicians.
The acquisition aims to leverage CD&R's and McKesson's expertise, as well as Option Care Health's clinical model and national infusion footprint across home and ambulatory sites.
Brian Tyler, chair and CEO of McKesson, highlighted the alignment of Option Care Health's strategy with the company's strategic goals around specialty care and access to complex services outside traditional healthcare settings. McKesson's oncology and multispecialty business unit reported $48.4 billion in revenue during 2025, a 31% year-over-year increase driven by acquisitions.
The company believes the acquisition is in line with its strategic objectives and sees Option Care Health's clinical model and national infusion footprint as well positioned for continued growth.
Written by urgent.news from Fierce Healthcare's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.